{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T03:12:35Z","timestamp":1794712355553,"version":"4.9.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","award":["2018YFC1312903"],"award-info":[{"award-number":["2018YFC1312903"]}],"id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870905"],"award-info":[{"award-number":["81870905"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission","doi-asserted-by":"publisher","award":["Z181100001818001"],"award-info":[{"award-number":["Z181100001818001"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.atherosclerosis.2021.10.002","type":"journal-article","created":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T10:57:59Z","timestamp":1634641079000},"page":"35-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Baseline or 90-day fibrinogen levels and long-term outcomes after ischemic stroke or TIA: Results from the China national stroke registry \u2162"],"prefix":"10.1016","volume":"337","author":[{"given":"Hui-Qing","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Long","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Song","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2021.10.002_bib1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1160\/TH07-08-0484","article-title":"Bornstein, Persistent hyperfibrinogenemia in acute ischemic stroke\/transient ischemic attack (TIA)","volume":"99","author":"Shenhar-Tsarfaty","year":"2008","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.atherosclerosis.2021.10.002_bib2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jns.2005.05.006","article-title":"Inflammatory response after acute ischemic stroke","volume":"236","author":"Marquardt","year":"2005","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.atherosclerosis.2021.10.002_bib3","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1161\/CIRCULATIONAHA.106.635029","article-title":"Relative value of inflammatory, hemostatic, and rheological factors for incident myocardial infarction and stroke: the Edinburgh Artery Study","volume":"115","author":"Tzoulaki","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2021.10.002_bib4","doi-asserted-by":"crossref","first-page":"3 080","DOI":"10.1161\/CIRCULATIONAHA.105.557132","article-title":"Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke? The Caerphilly Study","volume":"112","author":"Smith","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2021.10.002_bib5","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1161\/STROKEAHA.108.540492","article-title":"Fibrinogen independently predicts the development of ischemic stroke in a Taiwanese population: CVDFACTS study","volume":"40","author":"Chuang","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2021.10.002_bib6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1161\/01.STR.32.1.133","article-title":"Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke","volume":"32","author":"Di Napoli","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2021.10.002_bib7","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1161\/01.STR.0000019124.54361.08","article-title":"Inflammation, hemostatic markers, and antithrombotic agents in relation to long-term risk of new cardiovascular events in first-ever ischemic stroke patients","volume":"33","author":"Di Napoli","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2021.10.002_bib8","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1212\/WNL.0000000000002319","article-title":"Shared genetic susceptibility of vascular-related biomarkers with ischemic and recurrent stroke","volume":"86","author":"Williams","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.atherosclerosis.2021.10.002_bib9","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s11239-014-1122-1","article-title":"Hyperfibrinogenemia predicts long-term risk of death after ischemic stroke","volume":"38","author":"Swarowska","year":"2014","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.atherosclerosis.2021.10.002_bib10","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000346094","article-title":"Long-term survival of ischemic cerebrovascular disease in the acute inflammatory stroke study, a hospital-based cohort described by TOAST and ASCO","volume":"35","author":"Markaki","year":"2013","journal-title":"Cerebrovasc. Dis."},{"key":"10.1016\/j.atherosclerosis.2021.10.002_bib11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jns.2006.01.020","article-title":"Increased plasma fibrinogen predicts one-year mortality in patients with acute ischemic stroke","volume":"246","author":"Turaj","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.atherosclerosis.2021.10.002_bib12","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1161\/STROKEAHA.108.527804","article-title":"Hyperfibrinogenemia and functional outcome from acute ischemic stroke","volume":"40","author":"del Zoppo","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2021.10.002_bib13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1148\/radiol.2016151827","article-title":"Acute symptomatic basilar artery stenosis: MR imaging predictors of early neurologic deterioration and long-term outcomes","volume":"280","author":"Lee","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.atherosclerosis.2021.10.002_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000099","article-title":"Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events","volume":"6","author":"Sattar","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.atherosclerosis.2021.10.002_bib15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00281-011-0290-8","article-title":"Fibrinogen as a key regulator of inflammation in disease","volume":"34","author":"Davalos","year":"2012","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.atherosclerosis.2021.10.002_bib16","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1055\/s-0037-1613566","article-title":"Fibrin(ogen) in cardiovascular disease: an update","volume":"89","author":"Koenig","year":"2003","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.atherosclerosis.2021.10.002_bib17","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1160\/TH15-12-0938","article-title":"Haemostatic biomarkers are associated with long-term recurrent vascular events after ischaemic stroke","volume":"116","author":"Pedersen","year":"2016","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.atherosclerosis.2021.10.002_bib18","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1161\/01.STR.0000089015.51603.CC","article-title":"Inflammation and infections as risk factors for ischemic stroke","volume":"34","author":"Lindsberg","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2021.10.002_bib19","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/svn-2019-000242","article-title":"The Third China National Stroke Registry (CNSR-III) for patients with acute ischaemic stroke or transient ischaemic attack: design, rationale and baseline patient characteristics","volume":"4","author":"Wang","year":"2019","journal-title":"Stroke Vasc Neurol"},{"key":"10.1016\/j.atherosclerosis.2021.10.002_bib20","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018600","article-title":"Association of level and increase in D-dimer with all-cause death and poor functional outcome after ischemic stroke or transient ischemic attack","volume":"10","author":"Hou","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.atherosclerosis.2021.10.002_bib21","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1055\/s-0037-1614005","article-title":"A collaborative study to establish the 2nd International Standard for Fibrinogen","volume":"84","author":"Whitton","year":"2000","journal-title":"Plasma, Thromb. Haemost."},{"key":"10.1016\/j.atherosclerosis.2021.10.002_bib22","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1161\/CIRCULATIONAHA.106.634089","article-title":"Additive value of immunoassay-measured fibrinogen and high-sensitivity C-reactive protein levels for predicting incident cardiovascular events","volume":"114","author":"Mora","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2021.10.002_bib23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1161\/STROKEAHA.115.011035","article-title":"Plasma d-dimer and incident ischemic stroke and coronary heart disease: the atherosclerosis risk in communities study","volume":"47","author":"Folsom","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2021.10.002_bib24","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1161\/STROKEAHA.111.621649","article-title":"Diabetes and poor outcomes within 6 months after acute ischemic stroke: the China National Stroke Registry","volume":"42","author":"Jia","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2021.10.002_bib25","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1161\/STROKEAHA.116.015613","article-title":"Insulin resistance and prognosis of nondiabetic patients with ischemic stroke: the ACROSS-China study (abnormal glucose regulation in patients with acute stroke across China)","volume":"48","author":"Jing","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2021.10.002_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000145","article-title":"Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6","volume":"6","author":"Whiteley","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.atherosclerosis.2021.10.002_bib27","first-page":"1799","article-title":"Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis","volume":"294","author":"Danesh","year":"2005","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.atherosclerosis.2021.10.002_bib28","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1161\/ATVBAHA.115.306284","article-title":"Association of plasma \u03b3' fibrinogen with incident cardiovascular disease: the atherosclerosis risk in communities (ARIC) study, arterioscler","volume":"35","author":"Appiah","year":"2015","journal-title":"Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2021.10.002_bib29","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.atherosclerosis.2009.09.030","article-title":"The associations of interleukin-6 (IL-6) and downstream inflammatory markers with risk of cardiovascular disease: the Caerphilly Study","volume":"209","author":"Patterson","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2021.10.002_bib30","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/ATVBAHA.112.300109","article-title":"Multiple biomarkers for the prediction of ischemic stroke: the PRIME study","volume":"33","author":"Prugger","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2021.10.002_bib31","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1161\/01.STR.0000141701.36371.d1","article-title":"Fibrinogen concentration and risk of ischemic stroke and acute coronary events in 5113 patients with transient ischemic attack and minor ischemic stroke","volume":"35","author":"Rothwell","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2021.10.002_bib32","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s12967-016-1006-6","article-title":"Fibrinogen consumption is related to intracranial clot burden in acute ischemic stroke: a retrospective hyperdense artery study","volume":"14","author":"Pikija","year":"2016","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.atherosclerosis.2021.10.002_bib33","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrn.2018.13","article-title":"Fibrinogen in neurological diseases: mechanisms, imaging and therapeutics","volume":"19","author":"Petersen","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.atherosclerosis.2021.10.002_bib34","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1161\/01.STR.0000236636.39235.4f","article-title":"Role of fibrinogen levels and factor XIII V34L polymorphism in thrombolytic therapy in stroke patients","volume":"37","author":"Gonz\u00e1lez-Conejero","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2021.10.002_bib35","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1161\/STROKEAHA.107.505420","article-title":"Early disruption of the blood-brain barrier after thrombolytic therapy predicts hemorrhage in patients with acute stroke","volume":"39","author":"Kastrup","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2021.10.002_bib36","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/dneu.20954","article-title":"Extracellular matrix and matrix receptors in blood-brain barrier formation and stroke","volume":"71","author":"Baeten","year":"2011","journal-title":"Dev Neurobiol"},{"key":"10.1016\/j.atherosclerosis.2021.10.002_bib37","doi-asserted-by":"crossref","first-page":"566","DOI":"10.2353\/ajpath.2006.051066","article-title":"Cerebral ischemia-hypoxia induces intravascular coagulation and autophagy","volume":"169","author":"Adhami","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.atherosclerosis.2021.10.002_bib38","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1161\/CIRCULATIONAHA.112.122556","article-title":"CANTOS Pilot Investigative Group, Effects of interleukin-1\u03b2 inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial","volume":"126","author":"Ridker","year":"2012","journal-title":"Circulation"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915021013861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915021013861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:47:28Z","timestamp":1758156448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915021013861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":38,"alternative-id":["S0021915021013861"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.10.002","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Baseline or 90-day fibrinogen levels and long-term outcomes after ischemic stroke or TIA: Results from the China national stroke registry \u2162","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}